Distinct subtypes of serous ovarian carcinoma identified by p53 determinationLASSUS, Heini; LEMINEN, Arto; LUNDIN, Johan et al.Gynecologic oncology (Print). 2003, Vol 91, Num 3, pp 504-512, issn 0090-8258, 9 p.Article

Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCCLASSUS, Heini; SALOVAARA, Reijo; AALTONEN, Lauri A et al.The American journal of pathology. 2001, Vol 159, Num 1, pp 35-42, issn 0002-9440Article

Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patientsMOILANEN, Jarna; LASSUS, Heini; LEMINEN, Arto et al.Gynecologic oncology (Print). 2003, Vol 90, Num 2, pp 273-281, issn 0090-8258, 9 p.Article

Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomasNISKAKOSKI, Anni; KAUR, Sippy; RENKONEN-SINISALO, Laura et al.International journal of cancer (Print). 2013, Vol 133, Num 11, pp 2596-2608, issn 0020-7136, 13 p.Article

Combination of serum hCGp and p53 tissue expression defines distinct subgroups of serous ovarian carcinomaVARTIAINEN, Juhani; LASSUS, Heini; LEHTOVIRTA, Pentti et al.International journal of cancer. 2008, Vol 122, Num 9, pp 2125-2129, issn 0020-7136, 5 p.Article

Glycodelin in ovarian serous carcinoma: Association with differentiation and survivalMANDELIN, Erik; LASSUS, Heini; SEPPÄLÄ, Markku et al.Cancer research (Baltimore). 2003, Vol 63, Num 19, pp 6258-6264, issn 0008-5472, 7 p.Article

Comparison of serous and mucinous ovarian carcinomas : Distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4LASSUS, Heini; LAITINEN, Mika P. E; ANTTONEN, Mikko et al.Laboratory investigation. 2001, Vol 81, Num 4, pp 517-526, issn 0023-6837Article

Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinomaLASSUS, Heini; SIHTO, Harri; LEMINEN, Arto et al.Journal of molecular medicine (Berlin. Print). 2006, Vol 84, Num 8, pp 671-681, issn 0946-2716, 11 p.Article

Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinomaERKINHEIMO, Tiina-Liisa; LASSUS, Heini; FINNE, Patrik et al.Clinical cancer research. 2004, Vol 10, Num 2, pp 538-545, issn 1078-0432, 8 p.Article

A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in CancerNING LI; KAUR, Sippy; KATSAROS, Dionyssios et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 1, pp 154-164, issn 0008-5472, 11 p.Article

Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA let-7 Regulates Aldehyde Dehydrogenase 1-Positive Cancer Stem CellsXIAOJUN YANG; XIAOJUAN LIN; XIA ZHAO et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 22, pp 9463-9472, issn 0008-5472, 10 p.Article

MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian CancerNUO YANG; KAUR, Sippy; JOHNSTONE, Cameron N et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 24, pp 10307-10314, issn 0008-5472, 8 p.Article

Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinomaERKINHEIMO, Tiina-Liisa; LASSUS, Heini; SIVULA, Anna et al.Cancer research (Baltimore). 2003, Vol 63, Num 22, pp 7591-7594, issn 0008-5472, 4 p.Article